A drug powder is described and a process for its preparation, which comprises drug particles in amounts equal to or higher than 90% w/w, wherein said drug particles are at least partially coated with an amount lower than or equal to 2.0% w/w of an adjuvant which consists of one or a mixture of C12-C18 saturated fatty acid or their salts. The invention relates particularly to powder of tobramycin.

A drug powder for inhalation administration and a process thereof / Buttini, Francesca; Colombo, Paolo; Parlati, Chiara. - (2008).

A drug powder for inhalation administration and a process thereof

COLOMBO, Paolo;PARLATI, Chiara
2008

Abstract

A drug powder is described and a process for its preparation, which comprises drug particles in amounts equal to or higher than 90% w/w, wherein said drug particles are at least partially coated with an amount lower than or equal to 2.0% w/w of an adjuvant which consists of one or a mixture of C12-C18 saturated fatty acid or their salts. The invention relates particularly to powder of tobramycin.
A drug powder for inhalation administration and a process thereof / Buttini, Francesca; Colombo, Paolo; Parlati, Chiara. - (2008).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11381/2819707
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact